Source:http://linkedlifedata.com/resource/pubmed/id/16932246
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
1
|
| pubmed:dateCreated |
2006-8-25
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:status |
PubMed-not-MEDLINE
|
| pubmed:month |
Jan
|
| pubmed:issn |
1745-8366
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
2
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
12-3
|
| pubmed:year |
2006
|
| pubmed:articleTitle |
Does the nadir growth-hormone level predict response to somatostatin-analogue therapy?
|
| pubmed:affiliation |
Department of Endocrinology, Centre Hospitalier Universitaire de Liège, University of Liège, Belgium. albert.beckers@chu.ulg.ac.be
|
| pubmed:publicationType |
Journal Article
|